Pioneering Research. Trusted Medicines.
Advancing Human Health Through Innovation.
RIASMO LIFESCIENCES is committed to the discovery, development, and delivery of high-quality pharmaceutical products and therapeutic solutions globally.
Our Foundational Commitments
Driving value through rigorous science, ethical practice, and unwavering quality.
Targeted Drug Discovery
Focusing on novel small molecules and biologics to address unmet medical needs, driven by world-class scientific teams.
Global Quality Standards (GMP)
State-of-the-art manufacturing facilities ensuring compliance with Good Manufacturing Practices (GMP) and regulatory bodies.
Evidence-Based Clinical Trials
Conducting ethical and robust clinical studies to prove the efficacy and safety of our pipeline assets.
Our Therapeutic Divisions
Focused innovation to address critical global health challenges.
Oncology
Targeted therapies for solid tumors and hematological malignancies.
Cardiovascular
Solutions for hypertension, dyslipidemia, and chronic heart failure management.
Neurology
Research into neurodegenerative disorders and pain management.
Formulations
Developing stable and bioavailable generic and proprietary dosage forms.
Research & Development Pipeline
Our current assets driving innovation from preclinical discovery to market readiness.
RLS-001
Novel Kinase Inhibitor
Targeting specific resistance pathways in metastatic breast cancer. High potency demonstrated in preclinical models.
RLS-CVD1
Extended-Release Formulation
Once-daily therapy for managing severe cholesterol levels. Enhanced patient adherence profile.
RLS-Neuro2
Neuroprotectant Peptide
Potential therapeutic agent for early-stage Alzheimer's disease.
"Our dedication to patient safety and quality assurance is non-negotiable. Every product meets stringent international regulatory requirements."
— Dr. E. Sharma, Head of Quality Control
Partner With Our Research TeamR&D and Business Development Inquiry
We seek collaborative partners for licensing, co-development, and distribution.